Peru
Industry
BMI View: Although healthcare funding announcements by the Peruvian government promise to introduce much needed medicines and healthcare equipment, we note that its focus on large-scale...
2011-10-31Industry
BMI View: Despite President Ollanta Humala's government demonstrating a strong will to combat Peru's mounting healthcare problems, we maintain the view that the government's inability...
2011-10-10Industry
BMI View: A couple of months into President Ollanta Humala's presidency, we are beginning to see hints of protectionist policies play out. While it is important to ensure that pharmaceutical...
2011-08-16Industry
BMI View: While it is one thing to translate healthcare promises into healthcare policy, it is another to ensure funding resources are properly allocated. As such, Peru's recent announcement...
2011-08-05Industry
BMI View: Despite the high cost of medicines, we believe Peru's government is unlikely to abolish tax and tariff breaks for oncology, diabetes and HIV/AIDS medicines. Instead, the government...
2011-02-08Industry
BMI View: Multinational drugmakers will increasingly target domestic generic pharmaceutical firms in Latin America, given that such acquisitions provide instant market entry, distribution...
2011-01-28Industry
BMI View: Although Peru has still to overcome several institutional shortcomings in public services, the country's promising economic outlook and its government's commitment to increased...
2010-12-22Industry
The Peruvian pharmaceutical market is expected to show stronger than expected growth in 2010, based on figures released for 2009. According to the Comité de Productos para la Salud...
2010-04-08
